True Ileal Amino Acid Digestibility of Tenebrio Molitor Larvae in Women
NCT05885191 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5
Last updated 2024-04-17
Summary
Dietary protein intake of adequate quality is essential for human health. Traditional animal source foods play a key role in providing high quality protein but are associated with a high burden on the environment. Therefore, viable alternative protein sources are needed to be able to meet human nutritional needs for the rapidly increasing world population, while keeping food production within the planetary boundaries. T. molitor (Yellow Mealworm larvae) is a sustainably produced and commercially available edible insect, which contains a high quantity of protein with a favorable amino acid profile. Protein quality evaluation considers the amino acid composition as well as the ileal digestibility of the food's individual amino acids, to assess if human dietary requirements for essential amino acids can be met by the protein source. The present study will measure the digestibility of essential amino acids from T. molitor with a minimally invasive dual stable isotope tracer method that follows a plateau-fed test meal protocol. T. molitor will be intrinsically labelled with the stable isotope deuterium (2H), which will be given along with a reference amino acid mixture of known digestibility, labelled with the stable isotope carbon-13 (13C). Based on the results from the present study, protein quality of T. molitor as a protein source for human nutrition can be assessed, allowing a direct comparison of this novel protein source to other protein sources, such as meat and legumes.
Conditions
- Malnutrition; Protein
Interventions
- OTHER
-
2H intrinsically-labeled T.molitor with 13-C labeled amino acid mixture
Test meal with dried 2H intrinsically labeled T.molitor and 13C labeled reference amino acid mixture will be divided into 10 portions, which will be given hourly over the course of 7 hours. The first consumption will be the priming meal, comprised of 3 portions and will additionally contain 13C sodium bicarbonate.
Sponsors & Collaborators
-
Swiss Distance University of Applied Sciences
collaborator OTHER -
Swiss Federal Institute of Technology
collaborator OTHER -
St. John's Research Institute
collaborator OTHER -
Wageningen University and Research
collaborator OTHER -
Diego Moretti
lead OTHER
Principal Investigators
-
Diego Moretti, Prof. Dr. · Swiss Distance University of Applied Sciences
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-08-30
- Primary Completion
- 2023-11-30
- Completion
- 2024-04-16
Countries
- Switzerland
Study Locations
More Related Trials
-
Labelled Carbon Sucrose Breath Test (13C-SBT) as a Marker of Environmental Enteropathy
NCT04109352 ·Status: UNKNOWN
-
Novel Isotope Dilution Technique to Assess Vitamin A Status
NCT03000543 ·Status: COMPLETED ·Phase: NA
-
Intestinal Microbial Dysbiosis in Chinese Infants With Short Bowel Syndrome With Different Complications
NCT02699320 ·Status: COMPLETED
-
Palatability of an Oral Dispersible Tablet (ODT) Formulation in Children
NCT03581799 ·Status: COMPLETED ·Phase: NA
-
Fiber Tolerability in Children
NCT02519374 ·Status: COMPLETED ·Phase: NA
-
Patient and Observer Reported Outcome Measurements in Inborn Errors of Metabolism
NCT04248062 ·Status: COMPLETED
-
Role of the Gut Sweet Taste Receptor in the Secretion of Glucagon-like Peptide-1 and Peptide YY
NCT01304823 ·Status: COMPLETED ·Phase: PHASE1
-
Role of the Gut Sweet Taste Receptor in the Secretion of Satiation Peptides
NCT01302574 ·Status: COMPLETED ·Phase: PHASE1
-
Metabolic Evaluation of Nutrition in Rett Syndrome
NCT00786071 ·Status: COMPLETED
-
Gastrointestinal Dysfunction in Children Affected With Mitochondrial Disorders
NCT01137240 ·Status: COMPLETED
-
Treatment of Acetaminophen Toxicity With N-acetylcysteine
NCT00725179 ·Status: COMPLETED
-
Nutritional Aspects of Rett Syndrome
NCT00004656 ·Status: COMPLETED ·Phase: NA
-
Effects of EED on Zn Absorption and Retention in Children From a Standard Dose
NCT02760095 ·Status: COMPLETED
-
Tolerance of an Oral Nutritional Supplement(ONS)
NCT01782456 ·Status: COMPLETED ·Phase: NA
-
Creatine Metabolism in Rett Syndrome
NCT01198015 ·Status: COMPLETED
-
Sweet Taste Receptors and the Secretion of Glucagon-like Peptide-1 and Peptide YY
NCT01088841 ·Status: COMPLETED ·Phase: PHASE1
-
Tolerability of Enteral NAC in Infants
NCT06260566 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Methionine Metabolism in Parenterally Fed Pediatric Sepsis
NCT01891682 ·Status: COMPLETED
-
The Use of L-Carnitine And CoQ10 Supplements In the Treatment of Cyclic Vomiting Syndrome (CVS)
NCT00728104 ·Status: WITHDRAWN
-
Reference Values for Gastric Emptying
NCT02397577 ·Status: COMPLETED ·Phase: NA
-
Amino Acid Kinetics of GMP-AA in Healthy Human Volunteers
NCT05971563 ·Status: COMPLETED ·Phase: NA
-
Role of Topical Steroid Injection With Refractory Benign Esophageal Stricture Endoscopic Dilatation in Children
NCT06514079 ·Status: RECRUITING ·Phase: NA
-
Effects of Parenteral L-carnitine Supplementation in Premature Neonates
NCT00841295 ·Status: COMPLETED ·Phase: NA
-
The SKyRoCKeT Study
NCT05770817 ·Status: RECRUITING
-
Characterization of Intestinal Microbiota in Children With Inborn Errors of Metabolism (IEM)
NCT05330039 ·Status: COMPLETED